IMAX Corporation (IMAX) Q4 2025 Earnings Call Transcript
Wedbush reiterated its bullish stance on IMAX Corp (NYSE:IMAX), maintaining an ‘Outperform' rating and a $46 price target ahead of the company's fourth-quarter results, citing continued market share gains and a favorable content pipeline. Shares of IMAX traded hands at about $37 on Monday afternoon, up almost 40% in the last 12 months.
Imax (IMAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Film and television production and distribution companies like IMAX, WMG and TKO are thriving due to the heightened consumption of digital entertainment despite heavy spending on original programming and exclusive rights.
Imax (IMAX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Investors interested in Film and Television Production and Distribution stocks are likely familiar with Imax (IMAX) and Live Nation (LYV). But which of these two stocks is more attractive to value investors?
IMAX saw its stock jump more than 44% in 2025, and that was before the company announced that it had generated a record $1.28 billion at the global box office for the year. Meanwhile, shares of fellow theatrical stocks AMC, Cinemark and Marcus Theatres cratered.
IMAX Corporation: Strong Network Effect And Visible Growth Ahead
IMAX is a trendy entertainment stock, as the company had a fine 2025. Walt Disney has a much larger collection of revenue-producing assets across the entertainment realm, however.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
IMAX delivered ambitious mid-term guidance at its recent investor day, sparking a share price rally. Investor sentiment was dampened by uncertainty around a potential Warner Bros. deal and its implications for IMAX's box-office pipeline. Concerns focus on whether a WBD sale to Netflix would reduce theatrical releases or if a Paramount Skydance deal would trigger major studio budget cuts.
IMAX Corp (NYSE:IMAX) received a price target upgrade from Wedbush analysts following the company's 2025 Investor Day, with the firm raising its price target to $46 from $39 and maintaining an 'Outperform' rating. IMAX shares jumped more than 8% following the event, trading at about $38 in the early afternoon on Monday.